Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: regulation in response to cell density
about
"You Shall Not Pass"-tight junctions of the blood brain barrierA seamless trespass: germ cell migration across the seminiferous epithelium during spermatogenesisCoxsackievirus expression of the murine secretory protein interleukin-4 induces increased synthesis of immunoglobulin G1 in mice.Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells.Multiple phenotypes in adult mice following inactivation of the Coxsackievirus and Adenovirus Receptor (Car) geneToward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.Variations of coxsackievirus B3 capsid primary structure, ligands, and stability are selected for in a coxsackievirus and adenovirus receptor-limited environmentDisruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptorFiber and penton base capsid modifications yield diminished adenovirus type 5 transduction and proinflammatory gene expression with retention of antigen-specific humoral immunity.Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffolds.Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal woundsCytokine determinants of viral tropism.JAM-related proteins in mucosal homeostasis and inflammationNeutrophil-derived JAML inhibits repair of intestinal epithelial injury during acute inflammation.Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells.Assessment of a novel, capsid-modified adenovirus with an improved vascular gene transfer profileEnhanced Gene Delivery to Human Primary Endothelial Cells Using Tropism-Modified Adenovirus Vectors.
P2860
Q21129349-95983DCA-CA2E-4649-A912-1CBE687CD7A4Q28756756-921434F1-FC33-43CC-A781-91A02F69E5E7Q33810592-4029AE76-AAE5-4A07-A6AE-785D355E2885Q33866165-7467291F-24DD-4500-99A8-E1279D490D09Q33933004-09F1251D-2014-4583-9A13-1B128D6ECE6AQ34359584-FE8F63CD-C648-45C4-A2D7-45B677B537FBQ34742368-D1F628C8-E7FD-42C7-AE95-F99F319E5D1FQ34762639-7AF06047-F747-4829-8A8A-F1471E5270B8Q35139196-A502670D-019E-4732-82EA-682E52DB9AB2Q35156188-B029887E-BD19-4BB0-BEE3-E5305D18A19DQ36387908-7E97F504-D7DE-40D2-BBDE-CFFED1BE3CDCQ37583568-E4616114-FBFF-4DCB-904F-5CEE74A2E740Q38199343-01906502-8BB1-4447-930C-79CA0491159CQ39016237-5BC3B61C-1778-4E33-A4F3-422C1035CD83Q41039128-6C442493-0802-4A75-8D32-F7CEC0C345AFQ41842410-57A85805-8BC5-4263-85E2-83687EB39550Q41947416-EC5F08FA-3E60-48FB-AF38-26877B4F001F
P2860
Expression of the coxsackievirus and adenovirus receptor in cultured human umbilical vein endothelial cells: regulation in response to cell density
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Expression of the coxsackievir ...... on in response to cell density
@en
Expression of the coxsackievir ...... n in response to cell density.
@nl
type
label
Expression of the coxsackievir ...... on in response to cell density
@en
Expression of the coxsackievir ...... n in response to cell density.
@nl
prefLabel
Expression of the coxsackievir ...... on in response to cell density
@en
Expression of the coxsackievir ...... n in response to cell density.
@nl
P2093
P2860
P921
P1433
P1476
Expression of the coxsackievir ...... on in response to cell density
@en
P2093
N M Chapman
S D Carson
P2860
P304
P407
P577
1999-08-01T00:00:00Z